机构:[1]Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 610042, Chengdu, P. R. China.四川省人民医院四川省肿瘤医院[2]Guangxi Collaborative Innovation Center for Biomedicine (Guangxi-ASEAN Collaborative Innovation Center for Major Disease Prevention and Treatment), Guangxi Medical University, 530021, Nanning, Guangxi, China.[3]Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), 400038, Chongqing, China.[4]Department of Cancer Biology, Wake Forest Baptist Medical Center, Wake Forest University, Winston Salem, NC, 27101, USA.[5]Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 610042, Chengdu, P. R. China. xuchuan100@163.com.四川省人民医院四川省肿瘤医院[6]Department of Cancer Biology, Wake Forest Baptist Medical Center, Wake Forest University, Winston Salem, NC, 27101, USA. xuchuan100@163.com.
第一作者机构:[1]Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 610042, Chengdu, P. R. China.
推荐引用方式(GB/T 7714):
Li Wen,Li Feifei,Zhang Xia,et al.Correction: Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.[J].Signal transduction and targeted therapy.2022,7(1):31.doi:10.1038/s41392-022-00901-7.
APA:
Li Wen,Li Feifei,Zhang Xia,Lin Hui-Kuan&Xu Chuan.(2022).Correction: Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment..Signal transduction and targeted therapy,7,(1)
MLA:
Li Wen,et al."Correction: Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.".Signal transduction and targeted therapy 7..1(2022):31